Skip to main content
. 2023 Aug 1;15(8):4154–4171. doi: 10.21037/jtd-23-270

Table 6. Univariable and multivariable risk factors for MV dysfunction.

Variables Univariable analysis Multivariable analysis
HR 95% CI P value HR 95% CI P value
Age 1.001 0.992–1.009 0.895
Age ≤6 months 0.972 0.422–2.238 0.946
Weight 0.998 0.965–1.033 0.920
Weight ≤8 kg 1.023 0.488–2.144 0.953
Gender (male =0) 1.342 0.677–2.657 0.399
LVEF <0.6 before surgery 1.917 0.459–8.004 0.372
Annular diameter/BSA before surgery 1.009 0.991–1.028 0.316
LAD/BSA before surgery 1.007 0.996–1.019 0.235
LVEDD/BSA before surgery 1.004 0.993–1.016 0.487
LVSDD/BSA before surgery 1.009 0.991–1.027 0.321
LVEDVI before surgery 1.004 1.000–1.009 0.050 0.998 0.985–1.010 0.701
LVESVI before surgery 1.012 1.003–1.022 0.012 1.014 0.986–1.042 0.341
Double-orifice MV technique 2.580 0.615–10.824 0.195
Concomitant procedure 0.811 0.406–1.620 0.552
Without annuloplasty 0.672 0.342–1.321 0.249
Mixed mitral valve pathology 2.852 1.418–5.737 0.003 2.492 1.203–5.161 0.014
Isolated MR diseases 1.260 0.602–2.638 0.540
MR combined with CHD diseases 1.286 0.653–2.533 0.467
MS diseases 0.501 0.193–1.299 0.155
≥ moderate MV regurgitation before surgery 1.835 0.708–4.752 0.212
≥ moderate MV stenosis before surgery 0.708 0.308–1.631 0.418
Surgical era (2013 to 2016) 0.688 0.342–1.383 0.294

MV, mitral valve; HR, hazard ratio; CI, confidence interval; LVEF, left ventricular ejection fraction; BSA, body surface area; LAD, left atrium diameter; LVEDD, left ventricular end-diastolic diameter; LVSDD, left ventricular end-systolic diameter; LVEDVI (LVEDV/BSA), left ventricular end-diastolic volume index; LVESVI (LVESV/BSA), left ventricular end-systolic volume index; MR, mitral valve regurgitation; CHD, congenital heart diseases; MS, mitral valve stenosis.